Baudax Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Baudax Bio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18% to $1,269,000. Profit margin reached -4633%. Total operating expenses were $30,003,000.

Profit Margin

Baudax Bio, Inc. (NASDAQ:BXRX): Profit margin
2017 0 -61.08M
2018 0 -73.66M
2019 0 -18.00M
2020 493K -76.1M -15436.11%
2021 1.08M -19.76M -1830.46%
2022 1.26M -58.79M -4633.18%

BXRX Income Statement (2017 – 2022)

2022 2021 2020 2019 2018 2017
Revenue
Revenue
1.26M1.08M493K000
Cost of revenue
7.00M2.44M1.73M000
Gross profit
-5.74M-1.36M-1.23M000
Operating exp.
Research and development
3.88M3.12M9.08M20.06M35.58M28.63M
Selling and marketing
9.40M00000
Total operating expenses
30.00M51.01M54.56M47.07M65.03M48.26M
Operating income
-56.81M-19.00M-74.78M-32.51M-73.53M-61.1M
Other income (expenses), net
-1.98M-763K-1.31M-38K-8.63M-12.82M
Income before tax
-58.79M-19.76M-76.1M-32.55M-73.66M-61.08M
Income tax expense
23.05M3.84M1.40M-14.55M-132K12.83M
Net income
-58.79M-19.76M-76.1M-18.00M-73.66M-61.08M
Earnings per share
Basic EPS
-177.3-361.16-5.71K-2.69K-11.36K-9.42K
Diluted EPS
-177.3-361.16-5.71K-2.69K-11.36K-9.42K
Data sourceData sourceData sourceData source